Literature DB >> 10966849

Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.

D DiCiommo1, B L Gallie, R Bremner.   

Abstract

Retinoblastoma has contributed much to the understanding of cancer. The protein product of the RB gene, pRB, is a multifaceted regulator of transcription which controls the cell cycle, differentiation and apoptosis in normal development of specific tissues. Elucidating the mechanisms in which pRB plays a critical role will enable novel therapies and strategies for prevention, not only for retinoblastoma, but for cancer in general. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966849     DOI: 10.1006/scbi.2000.0326

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  26 in total

1.  Residential Pesticide Exposures in Pregnancy and the Risk of Sporadic Retinoblastoma: A Report From the Children's Oncology Group.

Authors:  Negar Omidakhsh; Arupa Ganguly; Greta R Bunin; Ondine S von Ehrenstein; Beate Ritz; Julia E Heck
Journal:  Am J Ophthalmol       Date:  2017-01-26       Impact factor: 5.258

2.  In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line.

Authors:  Rohini M Nair; Murali Ms Balla; Imran Khan; Ravi Kiran Reddy Kalathur; Paturu Kondaiah; Geeta K Vemuganti
Journal:  BMC Cancer       Date:  2017-11-21       Impact factor: 4.430

3.  The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.

Authors:  Sanja Pajovic; Timothy W Corson; Clarellen Spencer; Helen Dimaras; Marija Orlic-Milacic; Mellone N Marchong; Kwong-Him To; Brigitte Thériault; Mark Auspitz; Brenda L Gallie
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 4.  Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.

Authors:  Uma M Sachdeva; Joan M O'Brien
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

5.  Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.

Authors:  I Lambertz; D Nittner; P Mestdagh; G Denecker; J Vandesompele; M A Dyer; J-C Marine
Journal:  Cell Death Differ       Date:  2009-12-18       Impact factor: 15.828

6.  Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.

Authors:  Christopher S Bryant; Sanjeev Kumar; Sreedhar Chamala; Jay Shah; Jagannath Pal; Mahdi Haider; Shelly Seward; Aamer M Qazi; Robert Morris; Assaad Semaan; Masood A Shammas; Christopher Steffes; Ravindra B Potti; Madhu Prasad; Donald W Weaver; Ramesh B Batchu
Journal:  Mol Cancer       Date:  2010-03-02       Impact factor: 27.401

7.  RB1 germ-line deletions in Argentine retinoblastoma patients.

Authors:  Cecilia Fernández; Karina Repetto; Viviana Dalamon; Fenanda Bergonzi; Veronica Ferreiro; Irene Szijan
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Cell type-specific effects of Rb deletion in the murine retina.

Authors:  David MacPherson; Julien Sage; Teresa Kim; Dennis Ho; Margaret E McLaughlin; Tyler Jacks
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

9.  Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma.

Authors:  Suzanne Richter; Kirk Vandezande; Ning Chen; Katherine Zhang; Joanne Sutherland; Julie Anderson; Liping Han; Rachel Panton; Patricia Branco; Brenda Gallie
Journal:  Am J Hum Genet       Date:  2002-12-18       Impact factor: 11.025

10.  Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.

Authors:  Sanjeev Kumar; Christopher S Bryant; Sreedhar Chamala; Aamer Qazi; Shelly Seward; Jagannath Pal; Christopher P Steffes; Donald W Weaver; Robert Morris; John M Malone; Masood A Shammas; Madhu Prasad; Ramesh B Batchu
Journal:  Mol Cancer       Date:  2009-04-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.